Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin addition to bevacizumab and fluoropyrimidine in elderly metastatic colorectal cancer
NCT01279681Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2011
- Primary completion
- Nov 2014
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin in colorectal cancer (CRC), sponsored by Cancer and Leukemia Group B. Started Jan 2011; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01279681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279681.